WellPoint says earnings could slightly exceed expectations
WellPoint Inc. said Tuesday that it expects 2012 earnings at the high end or slightly above a range that the health insurer reaffirmed last month.
Health Care & Life Sciences
Articles
Fiscal cliff deal threatens Indiana co-op health plan
Last week’s fiscal cliff bargain in Congress dealt a potentially fatal blow to a new health insurance plan, called Remedy Indiana, that was set to launch this year.
Spotlight falls on IU Health for flu shot firings
Indiana University Health got national attention last week for its decision to dismiss eight employees for refusing to get a flu vaccination. The Indianapolis-based hospital system fired three nurses and five other employees from its IU Health Goshen Hospital.
Big drug deals expected to return in 2013
Pharmaceutical companies including Pfizer Inc., Bristol-Myers Squibb Co. and Eli Lilly and Co. could be ready to start making major acquisitions again.
FDA proposes sweeping new food safety rules
The Food and Drug Administration on Friday proposed the most sweeping food safety rules in decades, requiring farmers and food companies to be more vigilant in the wake of deadly outbreaks in peanuts, cantaloupe and leafy greens.
Lilly’s 2013 profit forecast tops expectations
Eli Lilly and Co. forecasts its 2013 earnings will grow more than Wall Street expects even though the drugmaker will lose U.S. patent protection for two more key products in the new year.
Trial set to begin over pregnancy drug sold by Lilly
Four sisters diagnosed with breast cancer are suing Eli Lilly and Co., a former maker of DES, or diethylstilbestrol, a drug taken by their mother in the 1950s when she was pregnant. It could be the first of scores of such trials over the drug.
Decline in fitness club memberships pushes NIFS into arms of seniors
Health club on campus of IUPUI makes up for lost revenue by managing fitness and wellness programs for retirement communities.
Stock buyback continues at CNO
The Carmel-based owner of Bankers Life and other insurance companies has seen its stock rise as it restructures debt.
WellPoint completes $4.5B Amerigroup acquisition
The deal gives the Indianapolis insurer a bigger slice of the growing market of patients covered by Medicaid, the federal-state health program for low-income people.
Women’s physician building targeted for foreclosure
A lawsuit from the lender claims that Women’s Physician Group still owes $8.7 million on a $9 million loan it received for a northwest-side building.
Lilly agrees to pay $29.4M to settle SEC bribery charges
According to a statement released by the SEC, Eli Lilly paid $6.5 million—and in some cases gave jewelry and spa treatments—to win government contracts in Brazil, China, Russia and Poland.
Indiana to receive nearly $793K in Amgen settlement
Amgen Inc. has agreed to pay Indiana nearly $793,000 as part of a larger settlement to resolve allegations it paid kickbacks to physicians who prescribed some of its drugs for unapproved uses.
Lilly finds solace in new Alzheimer’s study
Eli Lilly and Co. suffered a delay in its effort to bring an Alzheimer’s drug to market this month, but it also published new research that the pharmaceutical company thinks confirms it is on the right track.
Health care pricing service comes to Indy
Chicago-based OkCopay Inc. posts prices offered by Indianapolis health care providers, many of which have agreed to give cash-paying patients a price roughly equivalent to those charged to insured customers. The site also includes pricing information from health care providers that do not give cash-paying patients an additional break.
State expects to extend Healthy Indiana Plan a year
The Centers for Medicare and Medicaid Services agreed to a waiver that would allow the state to continue the program unchanged for a year.
Actuarial firm plans expansion at Indy office
Milliman Inc. said it will add 26 jobs by 2017 and invest $2 million to install additional information technology equipment at its office in downtown’s Chase Tower.
IEDC seeks $30M fund to stoke life sciences firms
The Indiana Economic Development Corp. is looking to renew its commitment to life sciences by creating a $30 million venture fund. The amount dedicated to one sector would be equal to the state’s allocation for all high-tech startups over the past two years.
Apartments, shops planned for old Beech Grove hospital site
Dubbed Franciscan Place, the $20 million development will feature 150-plus senior-living apartments, shops and a restaurant in the old hospital. Work is expected to begin in February.
Lilly discontinues late-stage trial in rheumatoid arthritis
Eli Lilly and Co. said it discontinued a last-stage trial of experimental rheumatoid arthritis drug tabalumab for lack of efficacy. Lilly is still evaluating the drug in the two other late-stage studies.